Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hyperbilirubinemia in the term newborn.

Meredith L Porter1, Beth L Dennis

  • 1Dewitt Army Community Hospital, Fort Belvoir, Virginia, USA. meredith.porter@vcz.amedd.army.mil

American Family Physician
|March 2, 2002
PubMed
Summary

Newborn jaundice, or hyperbilirubinemia, is common. Guidelines now recommend less intensive phototherapy for healthy term infants, focusing on preventing bilirubin neurotoxicity.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same journal

For Post-stent Patients With Atherosclerotic Coronary Vascular Disease Who Are Taking an Anticoagulant, Adding Aspirin Worsens Outcomes.

American family physician·2026
Same journal

Nausea and Vomiting During Pregnancy.

American family physician·2026
Same journal

Metabolic Dysfunction-Associated Steatotic Liver Disease: Diagnosis and Management.

American family physician·2026
Same journal

Aerobic Exercise Is the Better Exercise Modality for Knee Osteoarthritis.

American family physician·2026
Same journal

Overscreening Leads to Overdiagnosis of MASLD.

American family physician·2026
Same journal

Type 2 Diabetes: Outpatient Insulin Management.

American family physician·2026

Area of Science:

  • Neonatal Medicine
  • Pediatrics
  • Clinical Practice

Background:

  • Hyperbilirubinemia is a frequent issue in term newborns.
  • Historical management was based on hemolytic disease studies.
  • Current guidelines favor less intensive therapy for healthy term infants.

Purpose of the Study:

  • To outline current management guidelines for neonatal hyperbilirubinemia.
  • To differentiate physiologic from pathologic jaundice.
  • To prevent bilirubin-induced neurotoxicity in newborns.

Main Methods:

  • Review of current recommendations for phototherapy initiation.
  • Definition of criteria for pathologic jaundice.
  • Emphasis on clinical assessment to exclude serious underlying conditions.

Main Results:

  • Phototherapy guidelines based on infant age and total serum bilirubin levels.
  • Specific thresholds for initiating phototherapy: 15 mg/dL (25-48 hrs), 18 mg/dL (49-72 hrs), 20 mg/dL (>72 hrs).
  • Pathologic jaundice criteria include early onset, rapid rise, or high levels of bilirubin.

Conclusions:

  • Most term newborns with hyperbilirubinemia do not have severe pathology.
  • Management focuses on timely intervention to prevent neurotoxicity.
  • Clinical assessment is key to identifying and managing neonatal jaundice effectively.

Related Experiment Videos